Insulet
PODD
#1031
Rank
S$23.66 B
Marketcap
$337.05
Share price
0.37%
Change (1 day)
42.17%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.33

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.26. In 2022 the company made an earnings per share (EPS) of $0.09201 a decrease over its 2021 EPS that were of $0.30.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.332428.55%
2022$0.09201-69.57%
2021$0.30109.09%
2020$0.14-38.89%
2019$0.24200%
2018$0.07886-113.04%
2017-$0.60-9.8%
2016-$0.67-60.77%
2015-$1.7139.78%
2014-$1.2212.05%
2013-$1.09-23.15%
2012-$1.4210.2%
2011-$1.29-36.36%
2010-$2.02-36.63%
2009-$3.19-29.36%
2008-$4.52-86.74%
2007-$34.10-64.04%
2006-$94.83122.23%
2005-$42.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.66-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.25-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.29-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.51 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.91 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.58 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.14 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA